Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 1/2018

01-07-2018 | Review

Non-obstetrical indications for cesarean section: a state-of-the-art review

Authors: Roberta Venturella, Paola Quaresima, Mariella Micieli, Erika Rania, Annarita Palumbo, Federica Visconti, Fulvio Zullo, Costantino Di Carlo

Published in: Archives of Gynecology and Obstetrics | Issue 1/2018

Login to get access

Abstract

Purpose

To propose an evidence-based review on the most frequent indications for Cesarean section (CS) given by specialists in disciplines other than Obstetrics and Gynecology, with the aim of increasing consciousness about the available data in the literature and the guidelines recommendations about topics that are not frequently managed by obstetricians and gynecologists.

Methods

We analyzed hospital discharge data regarding deliveries occurred in a 10-year study period in our department to obtain the prevalence and the list of the most recurrent non-obstetrical indications for CS. A search was performed in PubMed, the Cochrane Library, SCOPUS, Web of Science and Ovid MEDLINE and only studies published in English from 1950 to 2017 were included. For indications for which no systematic reviews existed, we included the best available evidence, including guidelines of non-obstetrics scientific societies or organizations, RCTs, non-randomized controlled clinical trials, case–control studies, cohort studies, and case series.

Results

The rising rate of CS registered in the recent years is not justified by reduction in maternal––fetal risk or perinatal outcomes and often reflects inappropriate clinical behaviour and a wrong tendency that assimilates CS as a defensive practice. In a relevant percentage of cases, the indication to CS is given by specialists in other disciplines, even when specific guidelines do not give clear recommendation about the route of delivery.

Conclusions

To refuse non-obstetrical indications for CS, when scientific support is lacking, could be a useful and safe strategy to further reduce the rate of unnecessary CS.
Literature
1.
2.
3.
Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32:3147–3197CrossRef
4.
5.
Warnes CA (2015) Pregnancy and delivery in women with congenital heart disease. Circ J 79:1416–1421CrossRef
6.
Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr et al (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of women with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121:e266–e369PubMed
7.
Thompson JL, Kuklina EV, Bateman BT, Callaghan WM, James AH, Grotegut CA (2015) Medical and obstetric outcomes among pregnant women with congenital heart disease. Obstet Gynecol 126:346–354CrossRef
8.
Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK (2012) Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transfus 28:144–146CrossRef
9.
American College of Obstetricians and Gynecologists’ Committee on (2016) Practice bulletins—obstetrics. Practice bulletin no. 166: thrombocytopenia in pregnancy. Obstet Gynecol 128:e43–e53CrossRef
10.
Sainio S, Kekomäki R, Riikonen S, Teramo K (2000) Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 79:744–749CrossRef
11.
Myers B (2012) Diagnosis and management of maternal thrombocytopenia in pregnancy. Br J Haematol 158:3–15CrossRef
12.
13.
14.
Ali S, Jones GL, Culligan DJ, Marsden PJ, Russell N, Embleton ND et al (2015) Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy. Br J Haematol 170:487–495CrossRef
15.
Iancu G, Coviltir V, Iancu R, Corbu C (2013) Particularities of myopia in pregnancy. GINECOeu 9:196–199CrossRef
16.
Fernández-Montero A, Bes-Rastrollo M, Moreno-Montañés J, Moreno-Galarraga L, Martínez-González MÁ (2017) Effect of pregnancy in myopia progression: the SUN cohort. Eye (Lond) 31:1085–1092CrossRef
17.
Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR et al (2008) Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 31:1060–1079CrossRef
18.
19.
Sethi HS, Naik M, Gupta VS (2016) Management of glaucoma in pregnancy: risks and choices, a dilemma? Int J Ophthalmol 9:1684–1690PubMedPubMedCentral
20.
Meshi A, Armarnik S, Mimouni M, Segev F, Segal O, Kaneti H et al (2017) The effect of labor on the intraocular pressure in healthy women. J Glaucoma 26:59–64CrossRef
21.
Chiu H, Steele D, McAlister C, Lam WC (2015) Delivery recommendations for pregnant females with risk factors for rhegmatogenous retinal detachment. Can J Ophthalmol 50:11–18CrossRef
22.
Inglesby DV, Little BC, Chingnell AH (1990) Surgery for detachment of the retina should not affect a normal delivery. BMJ 300:980CrossRef
23.
Tincani A, Dall’Ara F, Lazzaroni MG, Reggia R, Andreoli L (2016) Pregnancy in patients with autoimmune disease: a reality in 2016. Autoimmun Rev 15:975–977CrossRef
24.
Davutoğlu EA, Ozel A, Yılmaz N, Madazli R (2017) Pregnancy outcome in 162 women with rheumatic diseases: experience of a university hospital in Turkey. Arch Gynecol Obstet 296(6):1079–1084CrossRef
25.
Wallenius M, Salvesen KÅ, Daltveit AK, Skomsvoll JF (2014) Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry. Acta Obstet Gynecol Scand 93:302–307CrossRef
26.
Jain V, Gordon C (2011) Managing pregnancy in inflammatory rheumatological diseases. Arthritis Res Ther 13:206CrossRef
27.
Branch DW (2004) Pregnancy in patients with rheumatic diseases: obstetric management and monitoring. Lupus 13:696–698CrossRef
28.
Knight CL, Nelson-Piercy C (2017) Management of systemic lupus erythematosus during pregnancy: challenges and solution. Open Access Rheumatol 9:37–53CrossRef
29.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306CrossRef
30.
Barnabe C, Faris PD, Quan H (2011) Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus. Int J Rheumatol 2011:345727CrossRef
31.
32.
Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS (2008) Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 65:805–815CrossRef
33.
Sydsjo G, Bladh M, Lilliecreutz C, Persson A, Vyöni H, Josefsson A (2014) Obstetric outcomes for nulliparous women who received routine individualized treatment for severe fear of childbirth—a retrospective case control study. BMC Pregnancy Childbirth 14:126CrossRef
34.
Holka-Pokorska J, Jarema M, Stefanowicz A, Piróg-Balcerzak A, Wichniak A (2016) Elective cesarean section on psychiatric indications—the phenomenon analysis, report of two cases and psychiatric clinical recommendations. Psychiatr Pol 50:357–373CrossRef
35.
36.
Andersson L, Sundström-Poromaa I, Bixo M, Wulff M, Bondestam K, Aström M (2003) Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol 189:148–154CrossRef
37.
Rusner M, Berg M, Begley C (2016) Bipolar disorder in pregnancy and childbirth: a systematic review of outcomes. BMC Pregnancy Childbirth 16:331CrossRef
38.
Hoff JM, Daltveit AK, Gilhus NE (2007) Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 14:38–43CrossRef
39.
Hoff JM, Daltveit AK, Gilhus NE (2003) Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology 61:1362–1366CrossRef
40.
Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA et al (2009) Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73:133–141CrossRef
41.
Viale L, Allotey J, Cheong-SeeFong F, Arroyo-Manzano D, Mccorry D, Bagary M et al (2015) Epilepsy in pregnancy and reproductive outcomes: a systematic review. Lancet 386:1845–1852CrossRef
42.
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A et al (2011) Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10:609–617CrossRef
43.
MacDonald SC, Bateman BT, McElrath TF, Hernandez-Diaz S (2015) Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the United States. JAMA Neurol 72:981–988CrossRef
44.
Veiby G, Daltveit AK, Engelsen BA, Gilhus NE (2009) Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia 50:2130–2139CrossRef
45.
Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520–532CrossRef
46.
Agarwal N, Guerra JC, Gala NB, Agarwal P, Zouzias A, Gandhi CD et al (2014) Current treatment options for cerebral arteriovenous malformations in pregnancy: a review of the literature. World Neurosurg 81:83–90CrossRef
47.
da Costa L, Wallace MC, Ter Brugge KG, O’Kelly C, Willinsky RA, Tymianski M (2009) The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke 40:100–105CrossRef
48.
Smith MW, Marcus PS, Wurtz LD (2008) Orthopedic issues in pregnancy. Obstet Gynecol Surv 63:103–111CrossRef
49.
Garmel SH, Guzelian GA, D’Alton JG, D’Alton ME (1997) Lumbar disk disease in pregnancy. Obstet Gynecol 89:821–822CrossRef
50.
Yazici Y, Erkan D, Zuniga R, Bateman H, Salvati EA, Magid SK (2003) Pregnancy outcomes following total hip arthroplasty: a preliminary study and review of the literature. Orthopaedics 26:75–76
51.
Sierra RJ, Trousdale RT, Cabanela ME (2005) Pregnancy and childbirth after total hip arthroplasty. J Bone Jt Surg Br 87:21–24CrossRef
52.
European Collaborative Study (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40:458–465CrossRef
53.
International Perinatal HIV Group, Andiman W, Bryson Y, de Martino M, Fowler M, Harris D et al (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies. N Engl J Med. 340:977–987CrossRef
54.
European Mode of Delivery Collaboration (1999) Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 353:1035–1039CrossRef
55.
Read JS, Newell MK (2005) Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev 2005:005479
56.
57.
McIntyre PG, Tosh K, McGuire W (2006) Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database Syst Rev 2006:CD0055468
58.
Rezk M, Omar Z (2017) Deleterious impact of maternal hepatitis-C viral infection on maternal and fetal outcome: a 5-year prospective study. Arch Gynecol Obstet 296(6):1097–1102CrossRef
59.
60.
61.
Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP (2009) Perinatal transmission of human papillomavirus DNA. Virol J 6:83CrossRef
62.
Kosko JR, Derkay CS (1996) Role of cesarean section in prevention of recurrent respiratory papillomatosis—is there one? Int J Pediatr Otorhinolaryngol 35:31–38CrossRef
Metadata
Title
Non-obstetrical indications for cesarean section: a state-of-the-art review
Authors
Roberta Venturella
Paola Quaresima
Mariella Micieli
Erika Rania
Annarita Palumbo
Federica Visconti
Fulvio Zullo
Costantino Di Carlo
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 1/2018
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-018-4742-4

Other articles of this Issue 1/2018

Archives of Gynecology and Obstetrics 1/2018 Go to the issue

Maternal-Fetal Medicine

Placenta accreta and balloon catheterization: the experience of a single center and an update of latest evidence of literature

Gynecologic Endocrinology and Reproductive Medicine

The diagnosis of PCOS in young infertile women according to different diagnostic criteria: the role of serum anti-Müllerian hormone

Gynecologic Endocrinology and Reproductive Medicine

Can a quality-of-life assessment assist in identifying women at risk of prematurely discontinuing IVF treatment? A prospective cohort study utilizing the FertiQoL questionnaire

General Gynecology

Study on the effects of an oral lactobacilli and lactoferrin complex in women with intermediate vaginal microbiota

Maternal-Fetal Medicine

Effect of maternal obesity on labor induction in postdate pregnancy

Gynecologic Oncology

Breast cancer patients’ satisfaction with individual therapy goals and treatment in a standardized integrative medicine consultancy service